Clinical Research Directory
Browse clinical research sites, groups, and studies.
Preclinical Assessment of an Engineered HMGB1 Protein as a Novel Companion Therapy for Muscular Dystrophies
Sponsor: IRCCS San Raffaele
Summary
This is a monocentric, no-profit, retrospective and prospective observational cohort study conducted at IRCCS Ospedale San Raffaele. The study does not entail any additional procedures or interventions for participants. Biological samples (including blood/serum and muscle biopsies) are obtained for a previously approved study (LAMA2\_GUP24002) and collected under the existing BancaINSpe informed consent. For the present study, analyses will be performed on biospecimens already stored or that will be stored at BancaINSpe, using portions of material already collected for the LAMA2\_GUP24002 protocol.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
25
Start Date
2026-08-01
Completion Date
2029-07
Last Updated
2026-08-04
Healthy Volunteers
No
Locations (1)
Irccs Ospedale San Raffaele
Milan, Italy